Joseph M. Patti
Director · Armata Pharmaceuticals, Inc.
- 2026
- Mar 12, 2026
- 1
Summary
Latest filing:
Joseph M. Patti is Director of Armata Pharmaceuticals, Inc. (ARMP). 1 SEC Form 4 filing on record, dated 12 March 2026.
Trading pattern
InsiderAlpha's records for Joseph M. Patti go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at Joseph M. Patti's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
- AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joseph M. Patti?
Joseph M. Patti is a corporate insider, tracked as Director of Armata Pharmaceuticals, Inc. (ARMP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Joseph M. Patti last file a Form 4?
The only primary Form 4 on record is dated 12 March 2026.